- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 3 residues within 4Å:- Chain A: W.446, N.474
- Chain C: E.497
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: W.181, L.182, G.183, P.487, D.488, N.491
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: E.430, R.455, L.484, N.485, P.487
Ligand excluded by PLIPEDO.5: 2 residues within 4Å:- Chain A: K.118, E.119
Ligand excluded by PLIPEDO.6: 2 residues within 4Å:- Chain A: R.309, D.315
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Ligands: EDO.21
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain B: E.497
- Chain D: W.446, N.474
- Ligands: EDO.52
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: W.446, N.474
- Chain D: E.497
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain B: G.65, V.67, W.318, R.330
- Ligands: FDA.15
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: Q.101, E.119, E.120
- Ligands: EDO.21
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain B: P.117, E.119
- Ligands: EDO.16, EDO.20
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: E.120, K.123
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain B: E.430, R.455, L.484, N.485, P.487
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: K.192
- Chain C: D.126
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain B: Q.110, M.128, M.152, M.153, A.188, P.189, N.190, V.194
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain B: A.204, G.205, W.207
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain B: R.99, N.400, E.402
Ligand excluded by PLIPEDO.36: 3 residues within 4Å:- Chain A: E.497
- Chain C: W.446, N.474
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain C: V.67, A.69, R.94, N.460
- Ligands: FDA.35
Ligand excluded by PLIPEDO.38: 6 residues within 4Å:- Chain C: W.181, L.182, G.183, P.487, D.488, N.491
Ligand excluded by PLIPEDO.39: 8 residues within 4Å:- Chain C: Q.110, M.128, M.152, M.153, A.188, P.189, N.190, V.194
Ligand excluded by PLIPEDO.40: 3 residues within 4Å:- Chain C: A.204, G.205, W.207
Ligand excluded by PLIPEDO.41: 2 residues within 4Å:- Chain C: R.309, D.315
Ligand excluded by PLIPEDO.50: 7 residues within 4Å:- Chain D: W.181, L.182, G.183, E.457, P.487, D.488, N.491
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain D: Q.110, M.152, A.188, P.189, N.190
Ligand excluded by PLIPEDO.52: 4 residues within 4Å:- Chain D: Q.441, N.474, E.481
- Ligands: EDO.17
Ligand excluded by PLIPEDO.53: 4 residues within 4Å:- Chain D: E.430, R.455, N.485, P.487
Ligand excluded by PLIP- 27 x SO4: SULFATE ION(Non-functional Binders)
SO4.7: 4 residues within 4Å:- Chain A: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: N.43, D.53, R.416
Ligand excluded by PLIPSO4.9: 2 residues within 4Å:- Chain A: K.73, R.499
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain A: T.155, R.163
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain A: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain A: P.84, K.85, E.86, D.87
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain A: T.140, K.141
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain B: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain B: N.386, T.389, D.393
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain B: N.43, D.53, R.416
Ligand excluded by PLIPSO4.31: 2 residues within 4Å:- Chain B: Y.90, T.91
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain B: K.73, R.499
Ligand excluded by PLIPSO4.33: 3 residues within 4Å:- Chain B: V.150, T.155, R.163
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain B: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain C: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain C: V.150, T.155, R.163
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain C: K.73, R.499
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain C: N.43, D.53, R.416
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain C: P.117, K.118
Ligand excluded by PLIPSO4.47: 3 residues within 4Å:- Chain C: R.94, Y.107, N.206
Ligand excluded by PLIPSO4.48: 3 residues within 4Å:- Chain C: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain D: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.55: 2 residues within 4Å:- Chain D: K.202, T.203
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain D: P.117, K.118
Ligand excluded by PLIPSO4.57: 3 residues within 4Å:- Chain D: V.150, T.155, R.163
Ligand excluded by PLIPSO4.58: 2 residues within 4Å:- Chain D: N.43, R.416
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 27 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D